Who has invested in NowRx?

Seedinvest, Decathlon Capital Partners are named among the investors backing NowRx.

NowRx Funding: $131M Raised, Series C (2022)

NowRx funding overview

NowRx is based in Mountain View, CA. NowRx has raised $131M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in April 2022. The round record for NowRx runs through 2022; nothing later has been disclosed. Investors on record include Seedinvest, Decathlon Capital Partners. 2 distinct backers are named across the disclosed rounds.

NowRx at a glance

Total raised: $131M
Latest round: Series C
Latest round date: April 2022
Headquarters: Mountain View, CA
Notable investors: Seedinvest, Decathlon Capital Partners

Frequently asked about NowRx funding

How much has NowRx raised?: NowRx has raised $131M in total disclosed funding across the rounds on record.
Who has invested in NowRx?: Seedinvest, Decathlon Capital Partners are named among the investors backing NowRx.
What was the latest NowRx funding round?: The most recent disclosed round is a Series C, announced in April 2022.
Where is NowRx based?: NowRx is based in Mountain View, CA.
When did NowRx last raise?: The last disclosed NowRx round closed in April 2022 at Series C.

Totals shown for NowRx aggregate every disclosed round on file. To see how that compares, browse the companies in Mountain View and the investors behind them below.

NowRx Funding: $131M Raised, Series C (2022)

NowRx funding overview

NowRx at a glance

Frequently asked about NowRx funding

Companies related to NowRx (18)

Browse related funding lists (3)